title: Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.
authors.forename: Inge
authors.initials: I
authors.lastname: Derdelinckx
authors.forename: Kristel
authors.initials: K
authors.lastname: Van Laethem
authors.forename: Bart
authors.initials: B
authors.lastname: Maes
authors.forename: Yoeri
authors.initials: Y
authors.lastname: Schrooten
authors.forename: Stéphane
authors.initials: S
authors.lastname: De Wit
authors.forename: Eric
authors.initials: E
authors.lastname: Florence
authors.forename: Katrien
authors.initials: K
authors.lastname: Fransen
authors.forename: Sergio García
authors.initials: SG
authors.lastname: Ribas
authors.forename: Denise
authors.initials: D
authors.lastname: Marissens
authors.forename: Michel
authors.initials: M
authors.lastname: Moutschen
authors.forename: Dolores
authors.initials: D
authors.lastname: Vaira
authors.forename: Georges
authors.initials: G
authors.lastname: Zissis
authors.forename: Marc
authors.initials: M
authors.lastname: Van Ranst
authors.forename: Eric
authors.initials: E
authors.lastname: Van Wijngaerden
authors.forename: Anne-Mieke
authors.initials: AM
authors.lastname: Vandamme
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D024882:Drug Resistance, Viral / Q000235:genetics; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D008297:Male; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors